Revenio Group Corporation’s Vice Chairman has been elected
The Board of Directors of Revenio Group Corporation has elected Vice Chairman among its members. Board member Bill Östman has been elected Vice Chairman. The Vice Chairman performs the duties of the Chairman of the Board when the Chairman of the Board is temporarily prevented from attending.
Revenio Group Corporation
Board of Directors
For further information, please contact:
Jouni Toijala, CEO, tel. +358 50 484 0085
Financial Supervisory Authority (FIN-FSA)
Revenio Group in brief
Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.
In 2021, the Group’s net sales totaled EUR 78.8 million, with an operating profit of EUR 22.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.